Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Contribution of CYP1B1 mutations and founder effect to primary congenital glaucoma in Mexico.
J Glaucoma. 2008 Apr-May;17(3):189-92. doi: 10.1097/IJG.0b013e31815678c3.
J Glaucoma. 2008.
PMID: 18414103
Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation.
Gonzalez JR, Baiza-Duran L, Quintana-Hau J, Tornero-Montaño R, Castaneda-Hernandez G, Ortiz M, Alarcon-Oceguera F, Beltran-Loustaunau M, Cortez-Gastelum M, Garcidueñas-Mejia J, Gomez-Bastar P, Jimenez-Roman J, Korder-Ortega V, Paczka-Zapata J, Torres-Segura M, Velasco-Gallegos G.
Gonzalez JR, et al. Among authors: korder ortega v.
J Clin Pharmacol. 2007 Jan;47(1):121-6. doi: 10.1177/0091270006292626.
J Clin Pharmacol. 2007.
PMID: 17192510
Clinical Trial.
Item in Clipboard
Cite
Cite